Evidence map›Paper›PMID 24829223›Full record

ReviewEMBO reports2014

Metabolomic strategies for the identification of new enzyme functions and metabolic pathways.

Gareth A Prosser, Gerald Larrouy-Maumus, Luiz Pedro S de Carvalho

Abstract readReview
In one paragraph

Review in EMBO reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. A cloaked glutamate decarboxylase sustains the GABA shunt inProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Leveraging 13C-Labeling to Assign Molecular Formulas to Unknown Yeast Metabolites.Journal of the American Society for Mass Spectrometry · 2026
    Article
  3. Article
  4. Article
  5. Plant Metabolomics: The Future of Anticancer Drug Discovery.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Aging Process: A Metabolomics Perspective.Molecules (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Review
  17. Discovery of Two Novel Oxidases Using a High-Throughput Activity Screen.Chembiochem : a European journal of chemical biology · 2022
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gareth A ProsserMycobacterial Research Division, MRC National Institute for Medical Research, London, UK.
Gerald Larrouy-MaumusMycobacterial Research Division, MRC National Institute for Medical Research, London, UK.
Luiz Pedro S de CarvalhoMycobacterial Research Division, MRC National Institute for Medical Research, London, UK luiz.pedro@nimr.mrc.ac.uk.

Funding

Medical Research Council MC_UP_A253_1111Medical Research Council MR/J006874/1
6 · The paper itself

Abstract

Recent technological advances in accurate mass spectrometry and data analysis have revolutionized metabolomics experimentation. Activity-based and global metabolomic profiling methods allow simultaneous and rapid screening of hundreds of metabolites from a variety of chemical classes, making them useful tools for the discovery of novel enzymatic activities and metabolic pathways. By using the metabolome of the relevant organism or close species, these methods capitalize on biological relevance, avoiding the assignment of artificial and non-physiological functions. This review discusses state-of-the-art metabolomic approaches and highlights recent examples of their use for enzyme annotation, discovery of new metabolic pathways, and gene assignment of orphan metabolic activities across diverse biological sources.

Indexed as

EnzymesGene Expression ProfilingIsotope LabelingMass SpectrometryMetabolic Networks and PathwaysMetabolomicsMolecular Sequence AnnotationEnzymesenzyme annotationmass spectrometrymetabolomicspathway discovery

Identifiers

PMID24829223
PMCPMC4197876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.